1. Home
  2. SMX vs LYRA Comparison

SMX vs LYRA Comparison

Compare SMX & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMX
  • LYRA
  • Stock Information
  • Founded
  • SMX N/A
  • LYRA 2005
  • Country
  • SMX Ireland
  • LYRA United States
  • Employees
  • SMX N/A
  • LYRA N/A
  • Industry
  • SMX Industrial Machinery/Components
  • LYRA Medical/Dental Instruments
  • Sector
  • SMX Technology
  • LYRA Health Care
  • Exchange
  • SMX Nasdaq
  • LYRA Nasdaq
  • Market Cap
  • SMX 6.7M
  • LYRA 7.4M
  • IPO Year
  • SMX N/A
  • LYRA 2020
  • Fundamental
  • Price
  • SMX $1.26
  • LYRA $20.25
  • Analyst Decision
  • SMX
  • LYRA Buy
  • Analyst Count
  • SMX 0
  • LYRA 2
  • Target Price
  • SMX N/A
  • LYRA $2.00
  • AVG Volume (30 Days)
  • SMX 55.3K
  • LYRA 1.5M
  • Earning Date
  • SMX 12-27-2024
  • LYRA 05-06-2025
  • Dividend Yield
  • SMX N/A
  • LYRA N/A
  • EPS Growth
  • SMX N/A
  • LYRA N/A
  • EPS
  • SMX N/A
  • LYRA N/A
  • Revenue
  • SMX N/A
  • LYRA $1,185,000.00
  • Revenue This Year
  • SMX N/A
  • LYRA N/A
  • Revenue Next Year
  • SMX N/A
  • LYRA $1,286.17
  • P/E Ratio
  • SMX N/A
  • LYRA N/A
  • Revenue Growth
  • SMX N/A
  • LYRA N/A
  • 52 Week Low
  • SMX $1.20
  • LYRA $3.81
  • 52 Week High
  • SMX $438.64
  • LYRA $37.50
  • Technical
  • Relative Strength Index (RSI)
  • SMX 34.83
  • LYRA 90.93
  • Support Level
  • SMX $1.21
  • LYRA $3.81
  • Resistance Level
  • SMX $1.39
  • LYRA $5.50
  • Average True Range (ATR)
  • SMX 0.09
  • LYRA 2.16
  • MACD
  • SMX -0.00
  • LYRA 1.02
  • Stochastic Oscillator
  • SMX 12.82
  • LYRA 48.80

About SMX SMX (Security Matters) Public Limited Company

SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: